XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study

20041,886 citationsJournal Articlebronze Open Access

Authors

Jarl Torgerson · Sahlgrenska University Hospital

Lars Sjöström · Sahlgrenska University Hospital

Abstract

Compared with lifestyle changes alone, orlistat plus lifestyle changes resulted in a greater reduction in the incidence of type 2 diabetes over 4 years and produced greater weight loss in a clinically representative obese population. Difference in diabetes incidence was detectable only in the IGT subgroup; weight loss was similar in subjects with IGT or NGT [correction].

Topics & Keywords

Pharmacology and Obesity Treatment Diabetes Treatment and Management Metabolism, Diabetes, and Cancer

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Care

Volume 27, Issue 1, pp. 155-161

DOI: 10.2337/diacare.27.1.155

Field-Weighted Citation Impact: 99.17